1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 RNA-Seq
1.2.3 Exome
1.3 Market by Application
1.3.1 Global NGS Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Lung cancer
1.3.4 Breast cancer
1.3.5 Prostate cancer
1.3.6 Colorectal cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NGS Services Market Perspective (2017-2028)
2.2 NGS Services Growth Trends by Region
2.2.1 NGS Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NGS Services Historic Market Size by Region (2017-2022)
2.2.3 NGS Services Forecasted Market Size by Region (2023-2028)
2.3 NGS Services Market Dynamics
2.3.1 NGS Services Industry Trends
2.3.2 NGS Services Market Drivers
2.3.3 NGS Services Market Challenges
2.3.4 NGS Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS Services Players by Revenue
3.1.1 Global Top NGS Services Players by Revenue (2017-2022)
3.1.2 Global NGS Services Revenue Market Share by Players (2017-2022)
3.2 Global NGS Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS Services Revenue
3.4 Global NGS Services Market Concentration Ratio
3.4.1 Global NGS Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS Services Revenue in 2021
3.5 NGS Services Key Players Head office and Area Served
3.6 Key Players NGS Services Product Solution and Service
3.7 Date of Enter into NGS Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS Services Breakdown Data by Type
4.1 Global NGS Services Historic Market Size by Type (2017-2022)
4.2 Global NGS Services Forecasted Market Size by Type (2023-2028)
5 NGS Services Breakdown Data by Application
5.1 Global NGS Services Historic Market Size by Application (2017-2022)
5.2 Global NGS Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NGS Services Market Size (2017-2028)
6.2 North America NGS Services Market Size by Country (2017-2022)
6.3 North America NGS Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe NGS Services Market Size (2017-2028)
7.2 Europe NGS Services Market Size by Country (2017-2022)
7.3 Europe NGS Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS Services Market Size (2017-2028)
8.2 Asia-Pacific NGS Services Market Size by Country (2017-2022)
8.3 Asia-Pacific NGS Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America NGS Services Market Size (2017-2028)
9.2 Latin America NGS Services Market Size by Country (2017-2022)
9.3 Latin America NGS Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS Services Market Size (2017-2028)
10.2 Middle East & Africa NGS Services Market Size by Country (2017-2022)
10.3 Middle East & Africa NGS Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Beijing Genomics Institute (BGI)
11.1.1 Beijing Genomics Institute (BGI) Company Detail
11.1.2 Beijing Genomics Institute (BGI) Business Overview
11.1.3 Beijing Genomics Institute (BGI) NGS Services Introduction
11.1.4 Beijing Genomics Institute (BGI) Revenue in NGS Services Business (2017-2022)
11.1.5 Beijing Genomics Institute (BGI) Recent Development
11.2 Cegat (Centre for Genomics and Transcriptomics) GMBH
11.2.1 Cegat (Centre for Genomics and Transcriptomics) GMBH Company Detail
11.2.2 Cegat (Centre for Genomics and Transcriptomics) GMBH Business Overview
11.2.3 Cegat (Centre for Genomics and Transcriptomics) GMBH NGS Services Introduction
11.2.4 Cegat (Centre for Genomics and Transcriptomics) GMBH Revenue in NGS Services Business (2017-2022)
11.2.5 Cegat (Centre for Genomics and Transcriptomics) GMBH Recent Development
11.3 DNA Vision SA
11.3.1 DNA Vision SA Company Detail
11.3.2 DNA Vision SA Business Overview
11.3.3 DNA Vision SA NGS Services Introduction
11.3.4 DNA Vision SA Revenue in NGS Services Business (2017-2022)
11.3.5 DNA Vision SA Recent Development
11.4 Eurofins Genomics Inc.
11.4.1 Eurofins Genomics Inc. Company Detail
11.4.2 Eurofins Genomics Inc. Business Overview
11.4.3 Eurofins Genomics Inc. NGS Services Introduction
11.4.4 Eurofins Genomics Inc. Revenue in NGS Services Business (2017-2022)
11.4.5 Eurofins Genomics Inc. Recent Development
11.5 Febit / Comprehensive Biomarker Center GMBH (CBC)
11.5.1 Febit / Comprehensive Biomarker Center GMBH (CBC) Company Detail
11.5.2 Febit / Comprehensive Biomarker Center GMBH (CBC) Business Overview
11.5.3 Febit / Comprehensive Biomarker Center GMBH (CBC) NGS Services Introduction
11.5.4 Febit / Comprehensive Biomarker Center GMBH (CBC) Revenue in NGS Services Business (2017-2022)
11.5.5 Febit / Comprehensive Biomarker Center GMBH (CBC) Recent Development
11.6 Genomnia SRL
11.6.1 Genomnia SRL Company Detail
11.6.2 Genomnia SRL Business Overview
11.6.3 Genomnia SRL NGS Services Introduction
11.6.4 Genomnia SRL Revenue in NGS Services Business (2017-2022)
11.6.5 Genomnia SRL Recent Development
11.7 Mina Inc.
11.7.1 Mina Inc. Company Detail
11.7.2 Mina Inc. Business Overview
11.7.3 Mina Inc. NGS Services Introduction
11.7.4 Mina Inc. Revenue in NGS Services Business (2017-2022)
11.7.5 Mina Inc. Recent Development
11.8 Macrogen Inc.
11.8.1 Macrogen Inc. Company Detail
11.8.2 Macrogen Inc. Business Overview
11.8.3 Macrogen Inc. NGS Services Introduction
11.8.4 Macrogen Inc. Revenue in NGS Services Business (2017-2022)
11.8.5 Macrogen Inc. Recent Development
11.9 Microsynth AG
11.9.1 Microsynth AG Company Detail
11.9.2 Microsynth AG Business Overview
11.9.3 Microsynth AG NGS Services Introduction
11.9.4 Microsynth AG Revenue in NGS Services Business (2017-2022)
11.9.5 Microsynth AG Recent Development
11.10 Seqomics
11.10.1 Seqomics Company Detail
11.10.2 Seqomics Business Overview
11.10.3 Seqomics NGS Services Introduction
11.10.4 Seqomics Revenue in NGS Services Business (2017-2022)
11.10.5 Seqomics Recent Development
11.11 Source Bio Science
11.11.1 Source Bio Science Company Detail
11.11.2 Source Bio Science Business Overview
11.11.3 Source Bio Science NGS Services Introduction
11.11.4 Source Bio Science Revenue in NGS Services Business (2017-2022)
11.11.5 Source Bio Science Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
